Search

Displaying all 2 results
DrugBest match

Romidepsin

go.drugbank.com/drugs/DB06176
ApprovedInvestigational

Romidepsin is a selective inhibitor of histone deacetylase, approved in the US in 2009 for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy.

  1. Indication

    Cutaneous T-Cell Lymphoma (CTCL)

    go.drugbank.com/conditions/DBCOND0071861
    Drugs: Cladribine · Gemcitabine · Interferon alfa-2a · Methoxsalen · Pralatrexate · Romidepsin